Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Olodaterol in Asthma
NCT01013753Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2010
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of olodaterol in asthma, sponsored by Boehringer Ingelheim. Started Feb 2010; status: completed.
02
Drugs
olodaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01013753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01013753.